Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut KANK4 163782 broad.mit.edu 37 1 62728946 62728946 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr1:62728946C>T ENST00000371153.4 - 7 2735 c.2357G>A c.(2356-2358)cGc>cAc p.R786H KANK4_ENST00000371150.1_Missense_Mutation_p.R142H|KANK4_ENST00000317477.4_5'UTR|KANK4_ENST00000354381.3_Missense_Mutation_p.R158H NM_181712.4 NP_859063.3 Q5T7N3 KANK4_HUMAN KN motif and ankyrin repeat domains 4 786 R -> H (in Ref. 1; BAC03774). NS(1)|breast(1)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(49)|ovary(3)|prostate(4)|skin(9)|stomach(1)|upper_aerodigestive_tract(2) 81 GCTGGAGACGCGGAACCACTC 0.562000 17 13 0 0 1 0 0 HLA-DQB2 3120 broad.mit.edu 37 6 32725567 32725567 + Missense_Mutation SNP C C T rs114234640 byFrequency TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr6:32725567C>T ENST00000435145.2 - 4 801 c.740G>A c.(739-741)cGt>cAt p.R247H HLA-DQB2_ENST00000411527.1_Intron|HLA-DQB2_ENST00000437316.2_Missense_Mutation_p.R247H Q5SR06 Q5SR06_HUMAN major histocompatibility complex, class II, DQ beta 2 216 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|immune response integral to membrane|MHC class II protein complex endometrium(1)|kidney(1)|lung(1)|prostate(2) 5 ACCCCTGTGACGGATGATAAG 0.552000 5 19 0 0 1 0 0 ANAPC1 64682 broad.mit.edu 37 2 112608394 112608394 + Missense_Mutation SNP T T C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:112608394T>C ENST00000341068.3 - 14 2381 c.1609A>G c.(1609-1611)Act>Gct p.T537A NM_022662.3 NP_073153.1 Q9H1A4 APC1_HUMAN anaphase promoting complex subunit 1 537 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|cell division|mitosis|mitotic cell cycle spindle assembly checkpoint|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|protein K11-linked ubiquitination anaphase-promoting complex|cytosol|nucleoplasm p.T537A(5) NS(1)|breast(1)|central_nervous_system(1)|cervix(2)|endometrium(6)|kidney(4)|large_intestine(7)|lung(16)|pancreas(1)|prostate(3)|skin(5)|stomach(1)|urinary_tract(1) 49 GGCTTTGGAGTACTAACGCCA 0.433000 3 66 0 0 1 0 0 AC024560.3 0 broad.mit.edu 37 3 197348668 197348668 + RNA SNP C C G rs79940815 by1000genomes TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr3:197348668C>G ENST00000418868.1 - 0 591 NR_003266.2 ACTTGAGGCTCTGTCCACCAA 0.488000 4 112 0 0 1 0 0 ANKRD36C 400986 broad.mit.edu 37 2 96593025 96593025 + Missense_Mutation SNP C C T rs75189823 by1000genomes TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:96593025C>T ENST00000456556.1 - 28 1960 c.1876G>A c.(1876-1878)Gat>Aat p.D626N ankyrin repeat domain 36C p.D626N(1) breast(1)|endometrium(8)|kidney(5)|lung(4) 18 TCTTTCTCATCACTTGTAGCC 0.318000 4 44 0 0 1 0 0 PGK1 5230 broad.mit.edu 37 X 77380495 77380495 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chrX:77380495C>T ENST00000373316.4 + 9 1228 c.1061C>T c.(1060-1062)gCt>gTt p.A354V PGK1_ENST00000537456.1_Missense_Mutation_p.A326V|PGK1_ENST00000476531.1_3'UTR|PGK1_ENST00000442431.1_Missense_Mutation_p.A218V NM_000291.3 NP_000282.1 P00558 PGK1_HUMAN phosphoglycerate kinase 1 354 gluconeogenesis|glycolysis cytosol ATP binding|phosphoglycerate kinase activity breast(1)|cervix(1)|endometrium(2)|kidney(3)|large_intestine(5)|lung(10)|ovary(1)|upper_aerodigestive_tract(1) 24 GGAACCAAAGCTCTCATGGAT 0.493000 12 68 0 0 1 0 0 POLQ 10721 broad.mit.edu 37 3 121158888 121158888 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr3:121158888C>T ENST00000264233.5 - 27 7468 c.7340G>A c.(7339-7341)cGt>cAt p.R2447H NM_199420.3 NP_955452.3 O75417 DPOLQ_HUMAN polymerase (DNA directed), theta 2447 DNA repair|DNA replication nucleoplasm ATP binding|ATP-dependent helicase activity|damaged DNA binding|DNA-directed DNA polymerase activity|single-stranded DNA-dependent ATPase activity NS(2)|breast(7)|central_nervous_system(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(16)|lung(55)|ovary(5)|prostate(3)|skin(4)|stomach(2)|upper_aerodigestive_tract(4)|urinary_tract(2) 120 GBM - Glioblastoma multiforme(114;0.0915) CAAATATCTACGCCTTCCCAA 0.328000 DNA polymerases (catalytic subunits) 19 32 0 0 1 0 0 RYR2 6262 broad.mit.edu 37 1 237730050 237730050 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr1:237730050G>A ENST00000366574.2 + 28 3715 c.3398G>A c.(3397-3399)cGt>cAt p.R1133H RYR2_ENST00000542537.1_Missense_Mutation_p.R1117H|RYR2_ENST00000360064.6_Missense_Mutation_p.R1131H NM_001035.2 NP_001026.2 Q92736 RYR2_HUMAN ryanodine receptor 2 (cardiac) 1133 4 X approximate repeats.|B30.2/SPRY 2. cardiac muscle contraction|detection of calcium ion|induction of apoptosis by ionic changes|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to caffeine|response to hypoxia|response to redox state calcium channel complex|cytosol|plasma membrane|plasma membrane enriched fraction|sarcoplasmic reticulum membrane calcium ion binding|calmodulin binding|identical protein binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|receptor activity|ryanodine-sensitive calcium-release channel activity|suramin binding NS(4)|breast(8)|central_nervous_system(11)|cervix(2)|endometrium(39)|haematopoietic_and_lymphoid_tissue(5)|kidney(17)|large_intestine(83)|liver(4)|lung(353)|ovary(18)|pancreas(5)|prostate(12)|skin(8)|stomach(1)|upper_aerodigestive_tract(12)|urinary_tract(4) 586 Ovarian(103;0.103) all_cancers(173;0.000368)|Melanoma(53;0.0179)|all_epithelial(177;0.0225) OV - Ovarian serous cystadenocarcinoma(106;0.00606) TCAGATGAACGTGCCTTTGCC 0.527000 88 126 0 0 1 0 0 TKT 7086 broad.mit.edu 37 3 53276168 53276168 + Silent SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr3:53276168C>T ENST00000462138.1 - 2 286 c.198G>A c.(196-198)ccG>ccA p.P66P TKT_ENST00000423525.2_Silent_p.P66P|TKT_ENST00000423516.1_Silent_p.P66P|TKT_ENST00000296289.6_Silent_p.P19P P29401 TKT_HUMAN transketolase 66 energy reserve metabolic process|xylulose biosynthetic process cytosol protein binding|transketolase activity endometrium(5)|large_intestine(4)|lung(4)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1) 17 Prostate(884;0.0959) BRCA - Breast invasive adenocarcinoma(193;0.000159)|OV - Ovarian serous cystadenocarcinoma(275;0.000314)|Kidney(197;0.00178)|KIRC - Kidney renal clear cell carcinoma(197;0.00201) Thiamine(DB00152) GGTCATTGTGCGGATTCCGGG 0.617000 4 103 0 0 1 0 0 RBM12B 389677 broad.mit.edu 37 8 94745679 94745679 + Missense_Mutation SNP T T C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr8:94745679T>C ENST00000399300.2 - 3 3173 c.2960A>G c.(2959-2961)aAt>aGt p.N987S RBM12B_ENST00000517700.1_Missense_Mutation_p.N867S|RP11-10N23.4_ENST00000517998.1_RNA|RBM12B_ENST00000520961.1_Intron NM_203390.2 NP_976324.2 Q8IXT5 RB12B_HUMAN RNA binding motif protein 12B 987 RRM 4. nucleotide binding|RNA binding breast(1)|endometrium(1)|kidney(1)|large_intestine(10)|lung(7)|ovary(2)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(2) 30 Breast(36;4.14e-07) BRCA - Breast invasive adenocarcinoma(8;0.0168) TGGCCTATCATTTAGATCTTT 0.378000 23 29 0 0 1 0 0 RP11-1166P10.6 0 broad.mit.edu 37 16 32070612 32070612 + RNA SNP A A C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr16:32070612A>C ENST00000566806.1 - 0 499 GGTCTCCTGCAAGGCTTCTGG 0.552000 5 81 0 0 1 0 0 NBPF10 100132406 broad.mit.edu 37 1 145367739 145367739 + Silent SNP A A G rs146714035 by1000genomes TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr1:145367739A>G ENST00000342960.5 + 83 10370 c.10335A>G c.(10333-10335)aaA>aaG p.K3445K NBPF10_ENST00000369338.1_Intron|NBPF10_ENST00000369339.2_Intron NM_001039703.4 NP_001034792.4 A6NDV3 A6NDV3_HUMAN neuroblastoma breakpoint family, member 10 3445 p.K3445K(4) NS(3)|breast(1)|central_nervous_system(3)|endometrium(12)|kidney(23)|lung(15)|ovary(1)|prostate(7)|skin(6)|urinary_tract(2) 73 all_hematologic(923;0.032) Colorectal(1306;1.36e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.00258) ggaaggggaaaaaaagaaggg 0.413000 4 58 0 0 1 0 0 MON2 23041 broad.mit.edu 37 12 62986483 62986483 + Missense_Mutation SNP A A G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr12:62986483A>G ENST00000393630.3 + 36 5502 c.5111A>G c.(5110-5112)gAt>gGt p.D1704G MON2_ENST00000393632.2_Missense_Mutation_p.D1703G|MON2_ENST00000551397.1_Missense_Mutation_p.D77G|MON2_ENST00000393629.2_Missense_Mutation_p.D1697G|MON2_ENST00000546600.1_3'UTR|MON2_ENST00000552738.1_Missense_Mutation_p.D1674G NM_001278470.1|NM_001278472.1 NP_001265399.1|NP_001265401.1 Q7Z3U7 MON2_HUMAN MON2 homolog (S. cerevisiae) 1704 Golgi to endosome transport|protein transport cytoplasm ARF guanyl-nucleotide exchange factor activity|binding NS(1)|breast(3)|central_nervous_system(2)|cervix(2)|endometrium(5)|kidney(3)|large_intestine(15)|lung(21)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1) 57 BRCA - Breast invasive adenocarcinoma(9;0.218) GBM - Glioblastoma multiforme(28;0.128) CCTTTTAAGGATTTCATGCAG 0.393000 26 43 0 0 1 0 0 DBNDD2 55861 broad.mit.edu 37 20 44037441 44037441 + Splice_Site SNP C C A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr20:44037441C>A ENST00000372712.2 + 3 721 c.139_splice c.e3-1 p.P47_splice SYS1-DBNDD2_ENST00000475242.1_3'UTR|DBNDD2_ENST00000357275.2_Splice_Site_p.P47_splice|DBNDD2_ENST00000372722.3_Splice_Site_p.P47_splice|DBNDD2_ENST00000360981.4_Splice_Site_p.P47_splice|DBNDD2_ENST00000372723.3_Splice_Site_p.P47_splice|DBNDD2_ENST00000372717.1_Splice_Site_p.P47_splice|DBNDD2_ENST00000372720.3_Splice_Site_p.P145_splice|DBNDD2_ENST00000372710.3_Splice_Site_p.P149_splice|SYS1-DBNDD2_ENST00000452133.1_3'UTR Q9BQY9 DBND2_HUMAN dysbindin (dystrobrevin binding protein 1) domain containing 2 145 negative regulation of protein kinase activity cytoplasm protein binding breast(1)|lung(2) 3 Myeloproliferative disorder(115;0.0122) TGATCCGCAGCCCCCATAGGT 0.517000 17 21 3.45872e-05 3.58923e-05 1 1 0 SLC25A52 147407 broad.mit.edu 37 18 29340011 29340011 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr18:29340011G>A ENST00000269205.5 - 1 832 c.644C>T c.(643-645)aCg>aTg p.T215M SLC25A52_ENST00000579441.2_Missense_Mutation_p.T205M NM_001034172.2 NP_001029344.3 Q3SY17 MCAR2_HUMAN solute carrier family 25, member 52 205 transport integral to membrane|mitochondrial inner membrane ACTGTGAGTCGTTGCGGTAGG 0.453000 8 62 0 0 1 0 0 PCNXL3 399909 broad.mit.edu 37 11 65397113 65397113 + Missense_Mutation SNP G G T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr11:65397113G>T ENST00000355703.3 + 26 4662 c.4123G>T c.(4123-4125)Gtc>Ttc p.V1375F NM_032223.2 NP_115599.2 Q9H6A9 PCX3_HUMAN pecanex-like 3 (Drosophila) 1375 integral to membrane breast(1)|endometrium(2)|kidney(2)|large_intestine(1)|lung(6)|prostate(1) 13 TGACTGCTTCGTCCTGGCCTC 0.617000 7 14 0.00198382 0.00202056 1 1 0 ANKRD36C 400986 broad.mit.edu 37 2 96593016 96593016 + Missense_Mutation SNP C C A rs79307257 by1000genomes TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:96593016C>A ENST00000456556.1 - 28 1969 c.1885G>T c.(1885-1887)Gat>Tat p.D629Y ankyrin repeat domain 36C p.D629Y(1) breast(1)|endometrium(8)|kidney(5)|lung(4) 18 GAAACAGAATCTTTCTCATCA 0.318000 4 45 0.00909568 0.00909568 1 1 0 ZNF438 220929 broad.mit.edu 37 10 31134429 31134429 + Missense_Mutation SNP C C G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr10:31134429C>G ENST00000538351.1 - 8 2555 c.1801G>C c.(1801-1803)Ggt>Cgt p.G601R ZNF438_ENST00000444692.2_Missense_Mutation_p.G640R|ZNF438_ENST00000436087.2_Missense_Mutation_p.G650R|ZNF438_ENST00000375311.1_Missense_Mutation_p.G214R|ZNF438_ENST00000442986.1_Missense_Mutation_p.G650R|ZNF438_ENST00000413025.1_Missense_Mutation_p.G650R|ZNF438_ENST00000331737.6_Missense_Mutation_p.G640R|ZNF438_ENST00000452305.1_Missense_Mutation_p.G640R|ZNF438_ENST00000361310.3_Missense_Mutation_p.G650R NM_001143769.1 NP_001137241.1 Q7Z4V0 ZN438_HUMAN zinc finger protein 438 650 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding breast(3)|central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(3)|lung(15)|ovary(1)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 35 Prostate(175;0.0587) TGACAACGACCACATTTGATT 0.393000 29 62 0 0 1 0 0 HTR3A 3359 broad.mit.edu 37 11 113856763 113856763 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr11:113856763C>T ENST00000504030.2 + 6 1016 c.571C>T c.(571-573)Cgc>Tgc p.R191C HTR3A_ENST00000535865.1_Intron|HTR3A_ENST00000299961.5_Missense_Mutation_p.R176C|HTR3A_ENST00000506841.2_Missense_Mutation_p.R191C|HTR3A_ENST00000375498.2_Missense_Mutation_p.R197C|HTR3A_ENST00000355556.2_Missense_Mutation_p.R197C P46098 5HT3A_HUMAN 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 191 digestion|synaptic transmission cell junction|integral to plasma membrane|postsynaptic membrane serotonin binding|serotonin receptor activity|serotonin-activated cation-selective channel activity p.R191G(1) central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(8)|lung(14)|prostate(1)|skin(4)|upper_aerodigestive_tract(3) 36 all_cancers(61;2.31e-17)|all_epithelial(67;2.1e-10)|all_hematologic(158;4.64e-05)|Melanoma(852;0.000312)|Acute lymphoblastic leukemia(157;0.000967)|Breast(348;0.0101)|all_neural(223;0.0281)|Prostate(24;0.0294)|Medulloblastoma(222;0.0425) BRCA - Breast invasive adenocarcinoma(274;2.71e-06)|Epithelial(105;2.58e-05)|all cancers(92;0.000238)|OV - Ovarian serous cystadenocarcinoma(223;0.191) Alosetron(DB00969)|Chloroprocaine(DB01161)|Cisapride(DB00604)|Dolasetron(DB00757)|Granisetron(DB00889)|Mirtazapine(DB00370)|Ondansetron(DB00904)|Palonosetron(DB00377)|Procaine(DB00721)|Tubocurarine(DB01199) CTCTTTGTGGCGCTTGCCAGA 0.527000 13 291 0 0 1 0 0 ERN2 10595 broad.mit.edu 37 16 23703565 23703565 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr16:23703565G>A ENST00000256797.4 - 18 2500 c.2332C>T c.(2332-2334)Cgc>Tgc p.R778C ERN2_ENST00000457008.2_Missense_Mutation_p.R678C NM_033266.3 NP_150296.3 Q76MJ5 ERN2_HUMAN endoplasmic reticulum to nucleus signaling 2 730 Protein kinase. apoptosis|induction of apoptosis|mRNA processing|negative regulation of transcription, DNA-dependent|rRNA catabolic process|transcription, DNA-dependent endoplasmic reticulum membrane|integral to membrane ATP binding|endoribonuclease activity, producing 5'-phosphomonoesters|magnesium ion binding|protein serine/threonine kinase activity large_intestine(2)|lung(2)|ovary(2) 6 GBM - Glioblastoma multiforme(48;0.0156) TTTGCCTGGCGATAAAGACTG 0.612000 55 77 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7577545 7577545 + Missense_Mutation SNP T T C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr17:7577545T>C ENST00000420246.2 - 7 868 c.736A>G c.(736-738)Atg>Gtg p.M246V TP53_ENST00000413465.2_Missense_Mutation_p.M246V|TP53_ENST00000359597.4_Missense_Mutation_p.M246V|TP53_ENST00000269305.4_Missense_Mutation_p.M246V|TP53_ENST00000455263.2_Missense_Mutation_p.M246V|TP53_ENST00000445888.2_Missense_Mutation_p.M246V NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 246 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain. M -> I (in sporadic cancers; somatic mutation).|M -> K (in sporadic cancers; somatic mutation).|M -> L (in sporadic cancers; somatic mutation).|M -> R (in sporadic cancers; somatic mutation).|M -> T (in sporadic cancers; somatic mutation).|M -> V (in LFS; germline mutation and in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.M246V(34)|p.0?(8)|p.?(5)|p.M246L(3)|p.G244_M246>V(3)|p.M246fs*1(2)|p.M153V(2)|p.M246_P250delMNRRP(2)|p.G151_M153>V(1)|p.G244fs*17(1)|p.C242fs*98(1)|p.G245fs*17(1)|p.C242_M246>L(1)|p.C238_M246delCNSSCMGGM(1)|p.G245fs*14(1)|p.G245fs*16(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CTCCGGTTCATGCCGCCCATG 0.577000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 25 50 0 0 1 0 0 ITIH6 347365 broad.mit.edu 37 X 54784549 54784549 + Missense_Mutation SNP A A G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chrX:54784549A>G ENST00000218436.6 - 8 1987 c.1958T>C c.(1957-1959)gTg>gCg p.V653A NM_198510.2 NP_940912.1 Q6UXX5 ITH5L_HUMAN inter-alpha-trypsin inhibitor heavy chain family, member 6 653 hyaluronan metabolic process extracellular region serine-type endopeptidase inhibitor activity GACCTTGGGCACCAAGGCTGG 0.532000 6 69 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000446179.1_Missense_Mutation_p.R132H|IDH1_ENST00000345146.2_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 30 33 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7577121 7577121 + Missense_Mutation SNP G G A rs121913343 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr17:7577121G>A ENST00000420246.2 - 8 949 c.817C>T c.(817-819)Cgt>Tgt p.R273C TP53_ENST00000413465.2_Intron|TP53_ENST00000359597.4_Missense_Mutation_p.R273C|TP53_ENST00000269305.4_Missense_Mutation_p.R273C|TP53_ENST00000455263.2_Missense_Mutation_p.R273C|TP53_ENST00000445888.2_Missense_Mutation_p.R273C NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 273 Interaction with AXIN1 (By similarity).|Interaction with DNA.|Interaction with E4F1.|Interaction with HIPK1 (By similarity). R -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> G (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> H (in LFS; germline mutation and in sporadic cancers; somatic mutation; abolishes sequence-specific DNA binding; dbSNP:rs28934576).|R -> L (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> N (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in sporadic cancers; somatic mutation).|R -> S (in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> Y (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R273C(481)|p.R273S(16)|p.R273G(9)|p.0?(8)|p.?(2)|p.R273fs*72(2)|p.R273fs*33(2)|p.R273fs*32(2)|p.V272>?(2)|p.F270fs*72(1)|p.R273_C275delRVC(1)|p.L265_K305del41(1)|p.S269fs*21(1)|p.E258fs*71(1)|p.R273fs*71(1)|p.F270_D281del12(1)|p.E271_R273delEVR(1)|p.V272_K292del21(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GCACAAACACGCACCTCAAAG 0.542000 R273C(8MGBA_CENTRAL_NERVOUS_SYSTEM)|R273C(BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(EFO27_OVARY)|R273C(KARPAS299_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(MFE319_ENDOMETRIUM)|R273C(NCIH1048_LUNG)|R273C(PANC0213_PANCREAS)|R273C(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(RDES_BONE)|R273C(RH30_SOFT_TISSUE)|R273C(RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SH10TC_STOMACH)|R273C(SJRH30_SOFT_TISSUE)|R273C(SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SW1710_URINARY_TRACT)|R273C(SW1783_CENTRAL_NERVOUS_SYSTEM)|R273C(TT2609C02_THYROID) 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 10 13 0 0 1 0 0 RGPD3 653489 broad.mit.edu 37 2 107041183 107041183 + Silent SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:107041183C>T ENST00000409886.3 - 20 3327 c.3240G>A c.(3238-3240)agG>agA p.R1080R RGPD3_ENST00000304514.7_Silent_p.R1080R NM_001144013.1 NP_001137485.1 A6NKT7 RGPD3_HUMAN RANBP2-like and GRIP domain containing 3 1080 RanBD1 1. intracellular transport binding breast(2)|central_nervous_system(1)|endometrium(50)|kidney(4)|lung(11)|ovary(1)|urinary_tract(2) 71 TCCCCAAGCCCCTTTCTTTCC 0.378000 175 268 0 0 1 0 0 SMIM19 114926 broad.mit.edu 37 8 42401645 42401645 + Silent SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr8:42401645C>T ENST00000438528.3 + 2 79 c.30C>T c.(28-30)gaC>gaT p.D10D SMIM19_ENST00000417410.2_Silent_p.D10D|SMIM19_ENST00000529505.1_3'UTR|SMIM19_ENST00000416469.2_Silent_p.D10D|SMIM19_ENST00000414154.2_Silent_p.D10D|SMIM19_ENST00000490331.2_Silent_p.D10D NM_001135676.1 NP_001129148.1 small integral membrane protein 19 TGATGGGTGACGATGGTTCTA 0.433000 42 107 0 0 1 0 0 SETD3 84193 broad.mit.edu 37 14 99865219 99865219 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr14:99865219C>T ENST00000331768.5 - 13 1741 c.1582G>A c.(1582-1584)Gag>Aag p.E528K NM_032233.2 NP_115609.2 Q86TU7 SETD3_HUMAN SET domain containing 3 528 peptidyl-lysine dimethylation|peptidyl-lysine monomethylation|peptidyl-lysine trimethylation|positive regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus histone methyltransferase activity (H3-K36 specific)|transcription coactivator activity NS(1)|central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(3)|large_intestine(8)|lung(8)|ovary(1)|skin(1) 25 all_cancers(154;0.224)|all_epithelial(191;0.0644)|Melanoma(154;0.0866) CCAGCCTCCTCCTCGAGGTTT 0.532000 69 92 0 0 1 0 0 FAM71F2 346653 broad.mit.edu 37 7 128315777 128315777 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr7:128315777G>A ENST00000480462.1 + 2 335 c.229G>A c.(229-231)Gtg>Atg p.V77M FAM71F2_ENST00000477515.1_Missense_Mutation_p.V77M|FAM71F2_ENST00000460349.1_3'UTR|FAM71F2_ENST00000378704.3_Missense_Mutation_p.V68M Q6NXP2 F71F2_HUMAN family with sequence similarity 71, member F2 77 NS(1)|cervix(1)|kidney(1)|large_intestine(2)|lung(2) 7 GTCTGCCACCGTGATCCTCGG 0.582000 3 44 0 0 1 0 0 CYP4F2 8529 broad.mit.edu 37 19 16006353 16006353 + Silent SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr19:16006353G>A ENST00000221700.5 - 3 401 c.306C>T c.(304-306)tgC>tgT p.C102C CYP4F2_ENST00000011989.7_Intron|CYP4F2_ENST00000592328.1_Intron NM_001082.3 NP_001073.3 P78329 CP4F2_HUMAN cytochrome P450, family 4, subfamily F, polypeptide 2 102 leukotriene metabolic process|long-chain fatty acid metabolic process|very long-chain fatty acid metabolic process|xenobiotic metabolic process endoplasmic reticulum membrane|microsome alkane 1-monooxygenase activity|electron carrier activity|heme binding|leukotriene-B4 20-monooxygenase activity|oxygen binding|protein binding p.C102C(1) NS(2)|breast(1)|endometrium(6)|kidney(2)|large_intestine(9)|liver(1)|lung(18)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(1) 46 TGTCGGGGTGGCACAAACTGA 0.597000 5 251 0 0 1 0 0 MAMLD1 10046 broad.mit.edu 37 X 149638129 149638129 + Missense_Mutation SNP T T A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chrX:149638129T>A ENST00000370401.2 + 4 594 c.284T>A c.(283-285)aTg>aAg p.M95K MAMLD1_ENST00000432680.2_Missense_Mutation_p.M70K|MAMLD1_ENST00000426613.2_Missense_Mutation_p.M70K|MAMLD1_ENST00000468306.1_3'UTR|MAMLD1_ENST00000262858.5_Missense_Mutation_p.M95K Q13495 MAMD1_HUMAN mastermind-like domain containing 1 95 male gonad development|regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus breast(1)|endometrium(4)|kidney(3)|large_intestine(12)|lung(14)|ovary(1)|prostate(2) 37 Acute lymphoblastic leukemia(192;6.56e-05) ACCCTTGCAATGGGCCCAGGT 0.517000 17 133 0 0 1 0 0 AC093642.5 0 broad.mit.edu 37 2 243037116 243037116 + RNA SNP T T A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:243037116T>A ENST00000456398.1 + 0 248 GCTGGAAGAATTGTGAATCTT 0.398000 5 71 0 0 1 0 0 ANKRD24 170961 broad.mit.edu 37 19 4202046 4202046 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr19:4202046G>A ENST00000600132.1 + 6 643 c.367G>A c.(367-369)Gcc>Acc p.A123T ANKRD24_ENST00000262970.5_Missense_Mutation_p.A213T|ANKRD24_ENST00000318934.4_Missense_Mutation_p.A123T NM_133475.1 NP_597732.1 Q8TF21 ANR24_HUMAN ankyrin repeat domain 24 123 endometrium(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(4)|lung(9)|prostate(1)|skin(1) 21 UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.0233)|STAD - Stomach adenocarcinoma(1328;0.181) CCACCTGGCCGCCAAATACGG 0.522000 4 87 0 0 1 0 0 OR1A2 26189 broad.mit.edu 37 17 3100860 3100860 + Silent SNP A A G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr17:3100860A>G ENST00000381951.1 + 1 48 c.48A>G c.(46-48)ggA>ggG p.G16G NM_012352.1 NP_036484.1 Q9Y585 OR1A2_HUMAN olfactory receptor, family 1, subfamily A, member 2 16 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity breast(1)|endometrium(4)|large_intestine(2)|lung(5)|skin(4)|stomach(2) 18 TTCTCCTGGGAGTTACTAGTC 0.398000 52 62 0 0 1 0 0 KIAA0753 9851 broad.mit.edu 37 17 6526324 6526324 + Missense_Mutation SNP G G C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr17:6526324G>C ENST00000361413.3 - 6 1340 c.982C>G c.(982-984)Cca>Gca p.P328A KIAA0753_ENST00000542606.1_Missense_Mutation_p.P29A|KIAA0753_ENST00000572370.1_Missense_Mutation_p.P29A NM_014804.2 NP_055619.2 Q2KHM9 K0753_HUMAN KIAA0753 328 centrosome endometrium(4)|large_intestine(11)|lung(5)|prostate(4) 24 COAD - Colon adenocarcinoma(228;0.157) GCAGGAAGTGGATGCTCCCCT 0.522000 4 61 0 0 1 0 0 ANKRD36C 400986 broad.mit.edu 37 2 96593000 96593000 + Missense_Mutation SNP A A G rs111976783 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:96593000A>G ENST00000456556.1 - 28 1985 c.1901T>C c.(1900-1902)aTa>aCa p.I634T ankyrin repeat domain 36C p.I634T(1) breast(1)|endometrium(8)|kidney(5)|lung(4) 18 TTCTGTGGCTATATTTGAAAC 0.338000 4 45 0 0 1 0 0 GLP1R 2740 broad.mit.edu 37 6 39046913 39046913 + Missense_Mutation SNP T T C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr6:39046913T>C ENST00000373256.4 + 10 1023 c.980T>C c.(979-981)gTc>gCc p.V327A NM_002062.3 NP_002053.3 P43220 GLP1R_HUMAN glucagon-like peptide 1 receptor 327 activation of adenylate cyclase activity|cAMP-mediated signaling|elevation of cytosolic calcium ion concentration|energy reserve metabolic process|regulation of insulin secretion integral to membrane|plasma membrane glucagon receptor activity|peptide receptor activity, G-protein coupled breast(5)|endometrium(3)|kidney(1)|large_intestine(8)|lung(9)|pancreas(1)|prostate(1)|skin(1)|stomach(2) 31 Exenatide(DB01276)|Glucagon recombinant(DB00040) TTTGTTCGGGTCATCTGCATC 0.557000 4 158 0 0 1 0 0 STK32C 282974 broad.mit.edu 37 10 134021578 134021578 + Missense_Mutation SNP T T C TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr10:134021578T>C ENST00000368622.1 - 12 1427 c.1046A>G c.(1045-1047)gAc>gGc p.D349G STK32C_ENST00000368625.4_Missense_Mutation_p.D479G Q86UX6 ST32C_HUMAN serine/threonine kinase 32C 466 Protein kinase. ATP binding|metal ion binding|protein serine/threonine kinase activity breast(1)|endometrium(2)|large_intestine(2)|lung(15)|ovary(2)|skin(1) 23 all_cancers(35;2.72e-11)|all_epithelial(44;2.33e-08)|Lung NSC(174;0.000855)|all_lung(145;0.00146)|all_neural(114;0.0299)|Breast(234;0.106)|Colorectal(31;0.112)|Melanoma(40;0.124)|Glioma(114;0.203) Epithelial(32;3.99e-05)|all cancers(32;5.58e-05)|OV - Ovarian serous cystadenocarcinoma(35;9.96e-05)|BRCA - Breast invasive adenocarcinoma(275;0.222) TTCCGCCTCGTCCTCCACAGG 0.706000 3 30 0 0 1 0 0 LL22NC03-80A10.6 0 broad.mit.edu 37 22 22664056 22664056 + RNA SNP T T C rs3178309 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr22:22664056T>C ENST00000426066.1 + 0 623 NR_027293.1 ATAAAGTATATGATTTTGTGT 0.348000 5 58 0 0 1 0 0 ESYT3 83850 broad.mit.edu 37 3 138192428 138192428 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr3:138192428G>A ENST00000389567.4 + 19 2474 c.2288G>A c.(2287-2289)cGc>cAc p.R763H ESYT3_ENST00000460133.1_3'UTR NM_031913.3 NP_114119.2 A0FGR9 ESYT3_HUMAN extended synaptotagmin-like protein 3 763 C2 3. integral to membrane|plasma membrane breast(1)|endometrium(5)|large_intestine(7)|lung(9)|prostate(1)|skin(1)|urinary_tract(1) 25 CTCACAGTGCGCTATGTGTGT 0.562000 62 93 0 0 1 0 0 AC093642.5 0 broad.mit.edu 37 2 243037115 243037115 + RNA SNP A A G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:243037115A>G ENST00000456398.1 + 0 247 GGCTGGAAGAATTGTGAATCT 0.398000 5 72 0 0 1 0 0 TTN 7273 broad.mit.edu 37 2 179443923 179443923 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr2:179443923C>T ENST00000589042.1 - 320 68058 c.67834G>A c.(67834-67836)Gat>Aat p.D22612N TTN_ENST00000591111.1_Missense_Mutation_p.D20971N|RP11-171I2.2_ENST00000603521.1_RNA|TTN-AS1_ENST00000592750.1_RNA|TTN-AS1_ENST00000419746.1_RNA|TTN-AS1_ENST00000592630.1_RNA|TTN-AS1_ENST00000592689.1_RNA|TTN-AS1_ENST00000592600.1_RNA|TTN-AS1_ENST00000591332.1_RNA|TTN-AS1_ENST00000586707.1_RNA|TTN-AS1_ENST00000590932.1_RNA|TTN-AS1_ENST00000590807.1_RNA|TTN_ENST00000342175.6_Missense_Mutation_p.D13739N|TTN-AS1_ENST00000586452.1_RNA|TTN-AS1_ENST00000438095.1_RNA|TTN-AS1_ENST00000585451.1_RNA|TTN_ENST00000342992.6_Missense_Mutation_p.D20044N|TTN_ENST00000460472.2_Missense_Mutation_p.D13547N|TTN-AS1_ENST00000586831.1_RNA|TTN-AS1_ENST00000456053.1_RNA|TTN_ENST00000359218.5_Missense_Mutation_p.D13672N NM_001267550.1 NP_001254479.1 Q8WZ42 TITIN_HUMAN titin 20971 Fibronectin type-III 64. ATP binding|nucleic acid binding|protein serine/threonine kinase activity|protein tyrosine kinase activity NS(24)|autonomic_ganglia(1)|breast(64)|central_nervous_system(14)|cervix(14)|endometrium(96)|haematopoietic_and_lymphoid_tissue(16)|kidney(91)|large_intestine(303)|liver(1)|lung(595)|ovary(58)|pancreas(17)|prostate(38)|skin(60)|stomach(29)|upper_aerodigestive_tract(1)|urinary_tract(26) 1448 OV - Ovarian serous cystadenocarcinoma(117;0.023)|Epithelial(96;0.0454)|all cancers(119;0.134) TTTTGGCAATCGTACACTATA 0.443000 38 50 0 0 1 0 0 FRG1B 0 broad.mit.edu 37 20 29614328 29614328 + Splice_Site SNP G G A rs137860963 by1000genomes TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr20:29614328G>A ENST00000278882.3 + 2 320 c.e2+1 FRG1B_ENST00000439954.2_Splice_Site|FRG1B_ENST00000358464.4_Splice_Site endometrium(10)|kidney(21)|lung(3)|pancreas(1)|prostate(9)|urinary_tract(9) 53 TGATACGTTGGTGAGTCAGTT 0.289000 3 27 0 0 1 0 0 IL9R 3581 broad.mit.edu 37 X 155234153 155234153 + Missense_Mutation SNP A A G TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chrX:155234153A>G ENST00000424344.3 + 6 806 c.439A>G c.(439-441)Atc>Gtc p.I147V IL9R_ENST00000244174.5_Missense_Mutation_p.I168V|IL9R_ENST00000540897.1_Missense_Mutation_p.I193V|IL9R_ENST00000369423.2_Missense_Mutation_p.I203V Q01113 IL9R_HUMAN interleukin 9 receptor 168 cell proliferation extracellular space|integral to plasma membrane interleukin-9 receptor activity NS(1)|central_nervous_system(1)|cervix(2)|endometrium(2)|kidney(3)|large_intestine(1)|lung(12)|upper_aerodigestive_tract(1) 23 all_cancers(53;1.86e-17)|all_epithelial(53;2.71e-11)|all_lung(58;1.84e-07)|Lung NSC(58;5.62e-07)|all_hematologic(71;2.45e-06)|Acute lymphoblastic leukemia(192;6.56e-05)|Breast(217;0.176)|Renal(33;0.214) GACCTGGAGCATCAGTCCTGC 0.547000 10 72 0 0 1 0 0 MLLT3 4300 broad.mit.edu 37 9 20414340 20414340 + Silent SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr9:20414340G>A ENST00000380338.4 - 5 790 c.504C>T c.(502-504)agC>agT p.S168S MLLT3_ENST00000429426.2_Silent_p.S165S|MLLT3_ENST00000475957.1_5'UTR|MLLT3_ENST00000355930.6_5'UTR NM_004529.2 NP_004520.2 P42568 AF9_HUMAN myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 168 Poly-Ser. regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus protein binding p.S168S(5) central_nervous_system(1)|cervix(1)|endometrium(13)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(6)|lung(24)|ovary(1)|prostate(4)|skin(1)|urinary_tract(7) 66 GBM - Glioblastoma multiforme(3;4.35e-105)|Lung(42;3.48e-06)|LUSC - Lung squamous cell carcinoma(42;7.92e-05) tgctgctgctgctactgctgc 0.537000 T MLL ALL 5 59 0 0 1 0 0 ZCWPW2 152098 broad.mit.edu 37 3 28566121 28566121 + Missense_Mutation SNP G G A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr3:28566121G>A ENST00000383768.2 + 10 1201 c.1013G>A c.(1012-1014)tGt>tAt p.C338Y ZCWPW2_ENST00000421010.1_Missense_Mutation_p.C338Y Q504Y3 ZCPW2_HUMAN zinc finger, CW type with PWWP domain 2 338 zinc ion binding haematopoietic_and_lymphoid_tissue(1)|large_intestine(8)|lung(6)|ovary(2) 17 GCTGGAGAATGTATTGAGGAT 0.303000 8 56 0 0 1 0 0 ATRX 546 broad.mit.edu 37 X 76939235 76939235 + Nonsense_Mutation SNP C C A TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chrX:76939235C>A ENST00000373344.5 - 9 1727 c.1513G>T c.(1513-1515)Gaa>Taa p.E505* ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Nonsense_Mutation_p.E467* NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 505 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TTGGCAGGTTCATATTGAGGT 0.383000 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 112 172 1.45418e-49 1.53807e-49 1 1 0 ZNF215 7762 broad.mit.edu 37 11 6977476 6977476 + Missense_Mutation SNP C C T TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr11:6977476C>T ENST00000278319.5 + 7 1856 c.1268C>T c.(1267-1269)aCt>aTt p.T423I ZNF215_ENST00000414517.2_Missense_Mutation_p.T423I|ZNF215_ENST00000529903.1_Intron NM_013250.2 NP_037382.2 Q9UL58 ZN215_HUMAN zinc finger protein 215 423 viral reproduction nucleus DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding NS(4)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(12)|ovary(1)|prostate(2)|skin(4) 32 Epithelial(150;6.33e-08)|BRCA - Breast invasive adenocarcinoma(625;0.134) ACAAACCTTACTAAGCATCAA 0.408000 7 31 0 0 1 0 0 POU4F2 5458 broad.mit.edu 37 4 147560457 147560458 + In_Frame_Ins INS - - GGC rs67907220 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr4:147560457_147560458insGGC ENST00000281321.3 + 1 413_414 c.165_166insGGC c.(163-168)gggcgg>ggGGCgcgg p.55_56GR>GAR AC093887.1_ENST00000584185.1_RNA NM_004575.2 NP_004566.2 Q12837 PO4F2_HUMAN POU class 4 homeobox 2 55 Poly-Gly. estrogen receptor signaling pathway|MAPKKK cascade|negative regulation of transcription from RNA polymerase II promoter nuclear speck RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription NS(1)|breast(1)|endometrium(7)|kidney(3)|large_intestine(11)|lung(8)|skin(1)|upper_aerodigestive_tract(1) 33 all_hematologic(180;0.151) ACGCTggtggtggcggcggcgg 0.762 7 9 --- --- --- --- CNTNAP2 26047 broad.mit.edu 37 7 146829342 146829342 + Frame_Shift_Del DEL T T - TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-10A-01D-2396-08 Untested Somatic Phase_I WXS none Illumina GAIIx 590efe82-cb5a-4e5e-943c-a8ebb1033776 da88f82c-7da0-4aec-97b0-11132dfb0ebb g.chr7:146829342delT ENST00000361727.3 + 8 1605 c.1089delT c.(1087-1089)aafs p.N363fs NM_014141.5 NP_054860.1 Q9UHC6 CNTP2_HUMAN contactin associated protein-like 2 363 Laminin G-like 1. behavior|cell adhesion|clustering of voltage-gated potassium channels|limbic system development|neuron recognition|signal transduction|striatum development|superior temporal gyrus development|thalamus development|transmission of nerve impulse axolemma|cell body fiber|dendrite|juxtaparanode region of axon|voltage-gated potassium channel complex receptor binding NS(3)|breast(2)|central_nervous_system(3)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(21)|lung(105)|ovary(9)|pancreas(2)|prostate(5)|skin(7)|stomach(3)|upper_aerodigestive_tract(6)|urinary_tract(3) 188 Melanoma(164;0.153) all_cancers(3;3.51e-10)|all_epithelial(3;1.4e-05)|Myeloproliferative disorder(3;0.00452)|Lung NSC(3;0.0067)|all_lung(3;0.00794) OV - Ovarian serous cystadenocarcinoma(82;0.0319) TACAGGGAAATTTGAGCTTTT 0.428 HNSCC(39;0.1) 64 54 --- --- --- ---